戻る戻るAN2 Therapeutics, Inc.のNet income before discontinued operations (非継続事業を含む純利益)
年間データ
−68.00 M
−51.00 M
−34.00 M
−17.00 M
0.00
直近12ヶ月
−60.70 M
+4.04 M
+6.23%
2023
−64.73 M
−23.78 M
−58.05%
2022
−40.96 M
−19.41 M
−90.11%
2021
−21.54 M
−7.94 M
−58.37%
2020
−13.60 M
−7.97 M
−141.40%
四半期データ
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−18.00 M
−13.50 M
−9.00 M
−4.50 M
0.00
Q3 '24
−12.75 M
+1.69 M
+11.69%
Q2 '24
−14.44 M
+2.18 M
+13.13%
Q1 '24
−16.62 M
+281.00 K
+1.66%
Q4 '23
−16.90 M
−191.00 K
−1.14%
Q3 '23
−16.71 M
−903.00 K
−5.71%
Q2 '23
−15.80 M
−481.00 K
−3.14%
Q1 '23
−15.32 M
−3.48 M
−29.40%
Q4 '22
−11.84 M
−503.00 K
−4.44%